Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT05362760 |
Title | Combination of Abemaciclib and Endocrine Therapy in Hormone Receptor Positive HER2 Negative Locally Advanced or Metastatic Breast Cancer With Focus on Digital Side Effect Management (MINERVA) |
Acronym | MINERVA |
Recruitment | Recruiting |
Gender | female |
Phase | FDA approved |
Variant Requirements | No |
Sponsors | Prof. W. Janni |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | DEU | CHE |